Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies

Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus

(2016) Akihito Sawada et al.   MICROBIOLOGY AND IMMUNOLOGY

Novel antigens for RSV vaccines

(2015) Barney S Graham et al.   CURRENT OPINION IN IMMUNOLOGY

Host Proteome Correlates of Vaccine-Mediated Enhanced Disease in a Mouse Model of Respiratory Syncytial Virus Infection

(2015) Angela van Diepen et al.   JOURNAL OF VIROLOGY

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

(2015) Geraldine Taylor et al.   Science Translational Medicine

RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets

(2015) Cory J. Knudson et al.   PLoS Pathogens

Lamb Model of Respiratory Syncytial Virus-Associated Lung Disease: Insights to Pathogenesis and Novel Treatments

(2014) M. R. Ackermann   ILAR JOURNAL

The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia

(2014) M. R. Olson et al.   JOURNAL OF IMMUNOLOGY

IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease

(2014) E. M. Castilow et al.   JOURNAL OF IMMUNOLOGY

Type 2 innate lymphoid cells constitutively express arginase-I in the naïve and inflamed lung

(2013) Jennifer K. Bando et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV

(2013) Rachel J. Derscheid et al.   PLoS One

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease

(2012) Christine A. Shaw et al.   VACCINE

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection

(2012) Rachel J. Derscheid et al.   Viruses-Basel

Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses

(2011) Alicia K. Olivier et al.   EXPERIMENTAL LUNG RESEARCH

Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006

(2011) Lauren J. Stockman et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV

(2011) Debby Kruijsen et al.   VACCINE

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

(2010) Barney S. Graham   IMMUNOLOGICAL REVIEWS

Gene Expression Differences in Lungs of Mice during Secondary Immune Responses to Respiratory Syncytial Virus Infection

(2010) A. Schuurhof et al.   JOURNAL OF VIROLOGY

The cotton rat model of respiratory viral infections

(2009) Marina S. Boukhvalova et al.   BIOLOGICALS

Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs

(2009) Alicia Olivier et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Pulmonary Eosinophilia Is Attenuated by Early Responding CD8+ Memory T Cells in a Murine Model of RSV Vaccine-Enhanced Disease

(2009) Whitney W. Stevens et al.   VIRAL IMMUNOLOGY

Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein

(2008) Teresa R. Johnson et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE